-
The COVID-19 pandemic poses major challenges to doctors and health systems worldwide. People with pre-existing health conditions have an even higher risk of experiencing a severe infection. Publications in medical journals and by independent organizations indicate that the exact measurement of vital parameters can play a major role in the treatment of risk groups with COVID-19. Height, weight, and vital signs such as blood pressure, oxygen saturation, pulse, and temperature are relevant for the exact dosage of medications and ventilator settings. In addition, this information helps with disease diagnosis and follow-up control measures.
Supply of hospitals, emergency departments and medical practices has the highest priority
-
In many countries, authorities and competent institutions have classified seca and its medical technology as system relevant to support health systems in the fight against the COVID 19 pandemic. Due to the current situation, the pressure in emergency rooms and hospitals is very high and the need for medical technology has continued to increase. The company is maintaining production and expanding capacities to best serve this demand and to contribute to the fight against the corona virus.
-
While the whole world is attempting to slow down the number of new infections with coronavirus, we are concentrating on protecting our employees and instituting measures to make sure our production in Hamburg remains fully operational. Our production site in Hangzhou has returned to 90 percent of production capacity since China ended its shutdown. That gives us hope and sends a positive signal to everyone. We take this opportunity to thank all our employees and partners whose support and engagement are keeping our products and service available to all who need them.
EU Medical Device Regulation successfully implemented three months before it fully comes into force
-
As one of the first Med Tech companies in Europe, seca is the global market leader in medical measuring and weighing and has passed the official MDR (Medical Device Regulation) audit even before the new EU regulation comes into effect in May 2020. Three auditors from the Notified Body (TÜV-SÜD Product Service) analyzed and audited the seca quality management system in accordance with the MDR requirements for medical devices and assessed all of them as successfully met.
The worldwide market leader focuses on future sustainability, optimized workflows and patient safety.
-
Guaranteed integration capacity for more patient safety, a new software solution for quick data access and individual product configuration for more orientation towards user needs – these promises are seca’s focal point of this year’s Medica. With product innovations from the categories Coreline, mBCA (medical Body Composition Analysis) and software, seca emphasizes the aspiration to now only develop user-oriented scales and length measuring systems, but also lives up to its role as worldwide market leader in innovative software and system providers. From 11/18 to 11/21/2019, Medica 2019 visitors can see for themselves the benefits of the new product solutions at seca’s booth (hall 12, booth…
System solutions from seca define new measuring standards and optimize workflows in hospitals around the world
-
Within the scope of Medicine 4.0, seca has long since moved beyond its strong portfolio of medical scales and height-measuring devices. For many years the company has made substantial investments in EMR-ready measuring solutions which optimize the ad hoc assessment of the patient's state of health. At this year's Arab Health seca will be presenting integrated system solutions that increase efficiency and patient safety in hospitals worldwide. At Hall 2 Stand H2.C19 visitors will see how seca optimizes workflows and taps diagnostic potential.
Validated BIA from seca conforms to consensus on diagnostic methods
-
The international societies ASPEN, ESPEN, FELANPE and PENSA established the Global Leadership Initiative in Malnutrition (GLIM) to build a worldwide consensus for diagnostic criteria for malnutrition. The consensus report published in September 2018 elevates reduced muscle mass to one of the decisive, independent evaluation criteria used in the diagnosis of malnutrition. seca welcomes this step, which the company sees as validation of its advocacy of improved diagnosis and treatment of malnutrition.
